Roberto Romandini
Senior Research Fellow, Max Planck Institute for Innovation and Competition,
Featured work
Should we revisit the patent system for pharmaceutical products?
Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effec